- 荣昌生物 (688331)- 净利润 之 形成过程

利润分析步骤二:分析 营业利润 到 净利润 的变化

营业利润

-7.7亿    ,-2.7,-4.3,-7.0,3.0,-10.0,-15.0,-7.7
了解明细
营业外收入

0.0亿    ,0.0,0.0,0.1,0.1,0.1,0.0,0.0
了解明细
营业外支出

0.1亿    ,0.0,0.0,0.0,0.4,0.1,0.1,0.1
了解明细
利润总额

-7.8亿    ,-2.7,-4.3,-7.0,2.8,-10.0,-15.1,-7.8
了解明细


净利润

-7.8亿    ,-2.7,-4.3,-7.0,2.8,-10.0,-15.1,-7.8
了解明细
所得税

0亿    ,0,0,0,0,0,0,0
了解明细


归母净利润

-7.8亿    ,-2.7,-4.3,-7.0,2.8,-10.0,-15.1,-7.8
了解明细
少数股东损益

0亿    ,0,0,0,0,0,0,0
了解明细
持续经营净利润

-7.8亿    ,-2.7,-4.3,-7.0,2.8,-10.0,-15.1,-7.8
了解明细
终止经营净利润

0亿    ,0,0,0,0,0,0,0
了解明细


归母其他综合收益

-0.3亿    ,0.0,0.0,0.0,0.1,0.0,-0.6,-0.3
了解明细
归少数股东其他综合收益

0亿    ,0,0,0,0,0,0,0
了解明细


归母综合收益总额

-8.1亿    ,-2.7,-4.3,-7.0,2.8,-10.0,-15.7,-8.1
了解明细
归少数股东综合收益总额

0亿    ,0,0,0,0,0,0,0
了解明细